Revolutionary Wireless Eye Implant Restores Vision for AMD Patients
In a monumental medical breakthrough announced today, a minuscule wireless retinal implant has successfully restored central vision to individuals blinded by advanced age-related macular degeneration (AMD). The results, published in the New England Journal of Medicine on March 2, 2026, reveal that over 80% of participants regained meaningful central vision within one year of receiving the implant.
The PRIMA (Photovoltaic Retina Implant Microarray) system, a creation of Science Corporation, is a 2×2 mm wireless implant placed under the retina. This innovative device works in tandem with specialized augmented-reality glasses. The PRIMA system replaces damaged photoreceptors and converts light into electrical signals, restoring communication between the eye and brain.
An international clinical trial, co-led by Dr. José-Alain Sahel of the UPMC Vision Institute, Dr. Daniel Palanker of Stanford University, and Dr. Frank Holz of the University of Bonn, saw 26 out of 32 participants (81%) achieve clinically meaningful improvements in visual acuity after one year. Impressively, 27 participants (84%) reported being able to read letters, words, and numbers at home using the prosthetic vision.
One patient, 70-year-old Sheila Irvine from London, described her life before the implant as “having two black discs in my eyes.” Now, she joyfully identifies as an “avid bookworm” once again, capable of doing crosswords and reading prescriptions. Following these promising results, Science Corporation has submitted applications seeking approval for clinical use in both Europe and the United States.
Source: Science Daily